(Q37932527)

25 August 2017

1 reference

title

Molecular studies of the Oka varicella vaccine (English)

1 reference

25 August 2017

2

1 reference

25 August 2017

Mark Quinlivan

1

1 reference

PubMed ID

21919621

25 August 2017

D Scott Schmid

series ordinal

3

1 reference

25 August 2017

1 September 2011

1 reference

Expert Review of Vaccines

25 August 2017

1 reference

25 August 2017

10

1 reference

25 August 2017

9

1 reference

25 August 2017

1321-1336

1 reference

Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?

25 August 2017

1 reference

Topics in herpesvirus genomics and evolution

21 January 2018

1 reference

Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers

21 January 2018

1 reference

Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay

21 January 2018

1 reference

Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency

21 January 2018

1 reference

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons

21 January 2018

1 reference

Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia

21 January 2018

1 reference

Persistence of varicella-zoster virus viraemia in patients with herpes zoster.

21 January 2018

1 reference

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses

21 January 2018

1 reference

Lymphocyte responses to varicella zoster virus in the elderly

21 January 2018

1 reference

A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.

21 January 2018

1 reference

Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation

21 January 2018

1 reference

Live vaccine used to prevent the spread of varicella in children in hospital

21 January 2018

1 reference

Assessment of virus infection in cultured cells using metabolic monitoring

21 January 2018

1 reference

Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome

21 January 2018

1 reference

The safety profile of varicella vaccine: a 10-year review

21 January 2018

1 reference

Varicella vaccination in Europe - taking the practical approach

21 January 2018

1 reference

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).

21 January 2018

1 reference

Postlicensure study of varicella vaccine effectiveness in a day-care setting

21 January 2018

1 reference

Varicella prevention in the United States: a review of successes and challenges

21 January 2018

1 reference

Loss of vaccine-induced immunity to varicella over time

21 January 2018

1 reference

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

21 January 2018

1 reference

Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic

21 January 2018

1 reference

The postmarketing safety profile of varicella vaccine

21 January 2018

1 reference

Varicella breakthrough infection and vaccine effectiveness in Taiwan.

21 January 2018

1 reference

Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine

21 January 2018

1 reference

Vaccine-associated herpes zoster ophthalmicus [correction of opthalmicus] and encephalitis in an immunocompetent child

21 January 2018

1 reference

Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child

21 January 2018

1 reference

Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.

21 January 2018

1 reference

Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine

21 January 2018

1 reference

Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child

21 January 2018

1 reference

Transmission of varicella vaccine virus to a non-family member in China

21 January 2018

1 reference

Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts

21 January 2018

1 reference

Secondary transmission of varicella vaccine virus in a chronic care facility for children

21 January 2018

1 reference

Live attenuated varicella virus vaccine. Efficacy trial in healthy children

21 January 2018

1 reference

The risk of zoster after varicella vaccination in children with leukemia

21 January 2018

1 reference

Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity

21 January 2018

1 reference

Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates

21 January 2018

1 reference

Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus

21 January 2018

1 reference

Complete DNA sequences of two oka strain varicella-zoster virus genomes

21 January 2018

1 reference

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts

21 January 2018

1 reference

Population diversity in batches of the varicella Oka vaccine

21 January 2018

1 reference

Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis

21 January 2018

1 reference

25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview

21 January 2018

1 reference

Comparative varicella vaccine effectiveness during outbreaks in day-care centres

21 January 2018

1 reference

Varicella vaccine effectiveness in the US vaccination program: a review

21 January 2018

1 reference

Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix).

21 January 2018

1 reference

Metaanalysis of vaccine effectiveness in varicella outbreaks.

21 January 2018

1 reference

Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses

21 January 2018

1 reference

Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens

21 January 2018

1 reference

Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells

21 January 2018

1 reference

Immune evasion during varicella zoster virus infection of keratinocytes

21 January 2018

1 reference

Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction

21 January 2018

1 reference

Varicella-zoster virus productively infects mature dendritic cells and alters their immune function

21 January 2018

1 reference

Modulation of major histocompatibility class II protein expression by varicella-zoster virus

21 January 2018

1 reference

Investigation of Varicella-Zoster Virus Infection by Polymerase Chain Reaction in the Immunocompetent Host with Acute Varicella

21 January 2018

1 reference

Characterization of viremia at different stages of varicella-zoster virus infection

21 January 2018

1 reference

Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus

21 January 2018

1 reference

Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella

21 January 2018

1 reference

Detection of varicella-zoster virus DNA in blood of children with varicella

21 January 2018

1 reference

DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine

21 January 2018

1 reference

Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates

21 January 2018

1 reference

Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts

21 January 2018

1 reference

Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster

21 January 2018

1 reference

Simian varicella virus DNA in dorsal root ganglia

21 January 2018

1 reference

Varicella-zoster virus infection of human dorsal root ganglia in vivo.

21 January 2018

1 reference

Varicella-zoster virus isolates, but not the vaccine strain OKA, induce sensitivity to alpha-1 and beta-1 adrenergic stimulation of sensory neurones in culture.

21 January 2018

1 reference

Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia.

21 January 2018

1 reference

Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo

21 January 2018

1 reference

Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor

21 January 2018

1 reference

Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection

21 January 2018

1 reference

Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo

21 January 2018

1 reference

Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA.

21 January 2018

1 reference

The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62.

21 January 2018

1 reference

Regulation of the expression of the varicella-zoster virus open reading frame 66 gene

21 January 2018

1 reference

Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

21 January 2018

1 reference

Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase

21 January 2018

1 reference

The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator

21 January 2018

1 reference

Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1.

21 January 2018

1 reference

Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase

21 January 2018

1 reference

Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex

21 January 2018

1 reference

The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades

21 January 2018

1 reference

Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus

21 January 2018

1 reference

Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins

21 January 2018

1 reference

Genome-wide reduction in transcriptomal profiles of varicella-zoster virus vaccine strains compared with parental Oka strain using long oligonucleotide microarrays

21 January 2018

1 reference

The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse

21 January 2018

1 reference

Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells

21 January 2018

1 reference

The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells

21 January 2018

1 reference

A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V)

21 January 2018

1 reference

Herpes simplex virus: receptors and ligands for cell entry

21 January 2018

1 reference

Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products

21 January 2018

1 reference

Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity

21 January 2018

1 reference

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model

21 January 2018

1 reference

Intracellular localization of varicella-zoster virus ORF39 protein and its functional relationship to glycoprotein K.

21 January 2018

1 reference

Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

21 January 2018

1 reference

Varicella-zoster virus-specific gpl40: A highly immunogenic and disulfide-linked structural glycoprotein

21 January 2018

1 reference

Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression

21 January 2018

1 reference

Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress

21 January 2018

1 reference

B-cell epitopes of varicella-zoster virus glycoprotein II.

21 January 2018

1 reference

Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo

21 January 2018

1 reference

Cytoplasmic domain signal sequences that mediate transport of varicella-zoster virus gB from the endoplasmic reticulum to the Golgi

21 January 2018

1 reference

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus

21 January 2018

1 reference

Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions

21 January 2018

1 reference

Vaccine Oka variants and sequence variability in vaccine-related skin lesions

21 January 2018

1 reference

Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus

21 January 2018

1 reference

Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations

21 January 2018

1 reference

An analytical method for R5 repeated structure in varicella-zoster virus DNA by polymerase chain reaction

21 January 2018

1 reference

Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain

21 January 2018

1 reference

Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain

21 January 2018

1 reference

Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping

21 January 2018

1 reference

The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation

21 January 2018

1 reference

New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis

21 January 2018

1 reference

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus

21 January 2018

1 reference

Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.

21 January 2018

1 reference

Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen

21 January 2018

1 reference

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

21 January 2018

1 reference

Modelling the impact of immunization on the epidemiology of varicella zoster virus

21 January 2018

1 reference

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

The epidemiology of varicella–zoster virus infections: the influence of varicella on the prevalence of herpes zoster

21 January 2018

1 reference

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 January 2018

1 reference

Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination

21 January 2018

1 reference

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX? in healthy children*1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.93

1 reference

25 August 2017

1 reference

PubMed ID

21919621